SeaCrest Wealth Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,211
Closed -$289K 670
2024
Q3
$289K Buy
10,211
+11
+0.1% +$284 0.03% 502
2024
Q2
$195K Buy
10,200
+600
+6% +$15.3K 0.02% 580
2024
Q1
$315K Sell
9,600
-100
-1% -$3.19K 0.04% 424
2023
Q4
$314K Sell
9,700
-180
-2% -$5.09K 0.04% 436
2023
Q3
$269K Buy
9,880
+100
+1% +$2.78K 0.04% 489
2023
Q2
$296K Buy
9,780
+130
+1% +$4.2K 0.04% 467
2023
Q1
$313K Buy
9,650
+150
+2% +$4.74K 0.04% 448
2022
Q4
$267K Buy
9,500
+400
+4% +$11.5K 0.04% 476
2022
Q3
$327K Sell
9,100
-50
-0.5% -$1.76K 0.05% 415
2022
Q2
$281K Buy
9,150
+149
+2% +$4.34K 0.04% 483
2022
Q1
$291K Buy
9,001
+250
+3% +$6.55K 0.03% 517
2021
Q4
$242K Sell
8,751
-1,100
-11% -$31.6K 0.03% 584
2021
Q3
$305K Hold
9,851
0.04% 488
2021
Q2
$208K Buy
+9,851
New +$197K 0.03% 640
2021
Q1
Sell
-10,637
Closed -$171K 663
2020
Q4
$171K Hold
10,637
0.02% 583
2020
Q3
$132K Sell
10,637
-250
-2% -$2.94K 0.02% 553
2020
Q2
$78K Buy
+10,887
New +$72.9K 0.01% 541
2019
Q2
Sell
-2,750
Closed -$35K 919
2019
Q1
$35K Sell
2,750
-1,500
-35% -$23.7K 0.01% 1066
2018
Q4
$85K Buy
4,250
+125
+3% +$2.89K 0.02% 717
2018
Q3
$117K Buy
4,125
+125
+3% +$2.98K 0.02% 690
2018
Q2
$84K Hold
4,000
0.02% 787
2018
Q1
$57K Sell
4,000
-475
-11% -$6.8K 0.01% 898
2017
Q4
$55K Buy
+4,475
New +$63.1K 0.01% 917

Other funds holding EVH

SeaCrest Wealth Management's EVH Position: Q4 2024 in Review

SeaCrest Wealth Management sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 10,211 shares — an estimated $289K sold.

SeaCrest Wealth Management first reported a position in EVH in Q4 2017 and held it in 23 quarters. The position peaked at $327K in Q3 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • SeaCrest Wealth Management reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • SeaCrest Wealth Management sold 10,211 Evolent Health shares in Q4 2024, an estimated $289K.
  • SeaCrest Wealth Management first reported a position in Evolent Health in Q4 2017 and held it in 23 quarters.
  • SeaCrest Wealth Management's Evolent Health position peaked at $327K in Q3 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on SeaCrest Wealth Management's 13F filing for Q4 2024, filed 14 Jan 2025.